Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Programmed cell death 1(PD-1)/programmed cell death ligand 1(PD-L1) have emerged as one of the most promising immune checkpoint targets for cancer immunotherapy. Despite the inherent advantages of small-molecule inhibitors over antibodies, the discovery of small-molecule inhibitors has fallen behind...
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Elsevier
2022-12-01
|
Serie: | Acta Pharmaceutica Sinica B |
Ämnen: | |
Länkar: | http://www.sciencedirect.com/science/article/pii/S2211383522001770 |